Skip to main content
PMC home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1992 Nov;35(6):365–372. doi: 10.1007/BF01789014

Quantitative autoradiographic evaluation of the influence of protein dose on monoclonal antibody distribution in human ovarian adenocarcinoma xenografts

Farley E Yang 1, Raya S Brown 1, Ken F Koral 1, Anaira C Clavo 1, Gayle A Jackson 1, Richard L Wahl 1,✉
PMCID: PMC11038642  PMID: 1394341

Abstract

We studied the effect of monoclonal antibody protein dose on the uniformity of radioiodinated antibody distribution within tumor masses using quantitative autoradiography. Groups (n = 11–13/group) of athymic nude mice with subcutaneous HTB77 human ovarian carcinoma xenografts were injected intraperitoneally with an125I-labeled anticarcinoma-associated antigen murine monoclonal antibody, 5G6.4, using a high or a low protein dose (500 µg or 5 µg). At 6 days post-injection the macroscopic and microscopic intratumoral biodistribution of radiolabeled antibody was determined. The degree of heterogeneity of the labeled antibody distribution within each tumor was quantified and expressed as thecoefficient of variation (CV) of the activity levels in serial histological sections. Tumors from mice given the 500-µg protein doses had substantially lower CV values, 0.327±0.027, than did tumors from animals given 5-µg protein doses, 0.458±0.041, (P = 0.0078), indicating that the higher protein dose resulted in more homogeneous distribution of radioactivity in tumors than did the lower dose. While the percentage of the injected dose reaching the tumor was comparable between groups, injecting the higher dose of protein resulted in significantly lower tumor to non-tumor uptake ratios than those obtained for the lower protein dose. These data indicate, in this system, that to achieve more uniform intratumoral antibody (and radiation for radioimmunotherapy) delivery, a relatively high protein dose must be administered. However, to obtain this increased uniformity, a substantial drop in tumor/background uptake ratios was seen. Quantitative autoradiographic evaluation of human tumor xenografts is a useful method to assess the intratumoral distribution of antibodies.

Key words: Monoclonal antibody, Ovarian carcinoma, Radiolabeled compounds, Quantitative autoradiography

References

  • 1.Badger CC, Krohn KA, Shulman H, Flournoy N, Bernstein ID. Experimental radioimmunotherapy of murine lymphoma with 131I-labeled anti-T-cell antibodies. Cancer Res. 1986;46:6223–6228. [PubMed] [Google Scholar]
  • 2.Blumenthal RD, Fand I, Sharkey RM, Boerman OC, Kashi R, Goldenberg DM. The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: an autoradiographic study. Cancer Immunol Immunother. 1991;33:351–358. doi: 10.1007/BF01741594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem. 1976;72:248–255. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  • 4.del Rosario RB, Baron LE, Lawton RG, Wahl RL. Streptavidin-biotinylated IgG conjugates: a simple procedure for reducing polymer formation. Technical note. Nucl Med Biol. 1992;19:417–421. doi: 10.1016/0883-2897(92)90128-l. [DOI] [PubMed] [Google Scholar]
  • 5.Esteban JM, Schlom J, Mornex F, Colcher D. Radioimmunotherapy of athymic mice bearing human colon carcinomas with monoclonal antibody B72.3: histological and autoradiographic study of effects on tumors and normal organs. Eur J Cancer Clin Oncol. 1987;23:643–655. doi: 10.1016/0277-5379(87)90259-8. [DOI] [PubMed] [Google Scholar]
  • 6.Fenwick JR, Philpott GW, Connett JM. Biodistribution and histological localization of anti-human colon cancer monoclonal antibody (MAb) 1A3: the influence of administered MAb dose on tumor uptake. Int J Cancer. 1989;44:1017–1027. doi: 10.1002/ijc.2910440614. [DOI] [PubMed] [Google Scholar]
  • 7.Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3l,6l-diphenylglycoluril. Biochem Biophys Res Commun. 1978;80:849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  • 8.Fujimori K, Covell DG, Fletcher JE, Weinstein JN. Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab′)2, and Fab in tumors. Cancer Res. 1989;15(49):5656–5663. [PubMed] [Google Scholar]
  • 9.Fujimori K, Fisher DR, Weinstein JN. Integrated microscopicmacroscopic pharmacology of monoclonal antibody radioconjugates: The radiation dose distribution. Cancer Res. 1991;15(51):4821–4827. [PubMed] [Google Scholar]
  • 10.Griffith MH, Yorke ED, Wessels BW, DeNardo GL, Neacy WP. Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy. J Nucl Med. 1988;29:1795–1809. [PubMed] [Google Scholar]
  • 11.Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29:577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  • 12.Jain RK. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst. 1989;81:570–576. doi: 10.1093/jnci/81.8.570. [DOI] [PubMed] [Google Scholar]
  • 13.Jain RK. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res [Suppl] 1990;50:814s–819s. [PubMed] [Google Scholar]
  • 14.Joftes DL. Radioautography, principles and procedures. J Nucl Med. 1963;4:143–154. [PubMed] [Google Scholar]
  • 15.Key ME, Bernhard MI, Hoyer LC, Foon KA, Oldham RK, Hanna MG. Guinea pig line 10 hepatocarcinoma model for monoclonal antibody serotherapy: in vivo localization of a monoclonal antibody in normal and malignant tissues. J Immunol. 1983;130:1451–1457. [PubMed] [Google Scholar]
  • 16.Koral KF, Kwok CS, Yang FE, Wahl RL. Variations in absorbed dose for radiolabeled monoclonal antibodies in a murine human-tumor xenograft. J Nucl Med. 1989;30:777. [Google Scholar]
  • 17.Kwok CS, Cole SE, Liao SK. Uptake kinetics of monoclonal antibodies by human malignant melanoma multicell spheroids. Cancer Res. 1988;48:1856–1863. [PubMed] [Google Scholar]
  • 18.Moshakis V, McIlhinney RA, Neville AM. Cellular distribution of monoclonal antibody in human tumours after I. V. administration. Br J Cancer. 1981;44:663–669. doi: 10.1038/bjc.1981.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ong GL, Mattes MJ. Penetration and binding of antibodies in experimental human solid tumors grown in mice. Cancer Res. 1989;1(49):4264–4273. [PubMed] [Google Scholar]
  • 20.Patt YZ, Lamki LM, Haynie TP, Unger MW, Rosenblum MG, Shirkhoda A, Murray JL. Improved tumor localization with increasing dose of indium111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE-025 in metastatic colorectal cancer. J Clin Oncol. 1988;6:1220–1230. doi: 10.1200/JCO.1988.6.8.1220. [DOI] [PubMed] [Google Scholar]
  • 21.Pervez S, Epenetos AA, Moor WJ, Evans DJ, Rowlinson G, Dhokia B, Krausz T. Localization of monoclonal antibody AUAl and its F(ab′)2 fragments in human tumour xenografts: an autoradiographic and immunohistochemical study. Int J Cancer [Suppl] 1988;3:23–29. doi: 10.1002/ijc.2910410806. [DOI] [PubMed] [Google Scholar]
  • 22.Sands H, Jones PL, Shah SA, Palme D, Vessella RL, Gallagher BM. Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Clouser and renal cell xenografts. Cancer Res. 1988;48:188–193. [PubMed] [Google Scholar]
  • 23.Schroff RW, Woodhouse CS, Foon KA, Oldham RK, Farrell MM, Klein RA, Morgan AC., Jr. Intratumoral localization of monoclonal antibody in patients with melanoma treated with antibody to a 250,000-dalton melanoma-associated antigen. J Natl Cancer Inst. 1985;74:299–306. [PubMed] [Google Scholar]
  • 24.Sharkey RM, Primus FJ, Goldenberg DM. Antibody protein dose and radioimmunodetection of GW-39 human colon tumor xenografts. Int J Cancer. 1987;39:611–617. doi: 10.1002/ijc.2910390512. [DOI] [PubMed] [Google Scholar]
  • 25.Sharkey RM, Natale A, Goldenberg DM, Mattes MJ. Rapid blood clearance of immunoglobulin G2a and immunoglobulin G2b in nude mice. Cancer Res. 1991;15(51):3102–3107. [PubMed] [Google Scholar]
  • 26.Thomas GD, Chappell MJ, Dykes PW, Ramsden DB, Godfrey KR, Ellis JRM, Bradwell AR. Effect of dose, molecular size, and protein binding on tumor uptake of antibody or ligand: a biomathematical model. Cancer Res. 1989;49:3290. [PubMed] [Google Scholar]
  • 27.Wahl RL. Radiolabeled monoclonal antibody imaging. Radiol Rep. 1989;1:347–361. [Google Scholar]
  • 28.Wahl RL, Philpott GW, Parker CW. Monoclonal antibody radioimmunodetection of human-derived colon cancer. Invest Radiol. 1983;18:58–62. doi: 10.1097/00004424-198301000-00010. [DOI] [PubMed] [Google Scholar]
  • 29.Wahl RL, Sherman P, Fisher S. The effect of specimen processing on radiolabeled monoclonal antibody biodistribution. Eur J Nucl Med. 1984;9:382–384. doi: 10.1007/BF00252876. [DOI] [PubMed] [Google Scholar]
  • 30.Wahl RL, Liebert M, Wilson BS. The influence of monoclonal antibody dose on tumor uptake of radiolabeled antibody. Cancer Drug Deliv. 1986;3:243–249. doi: 10.1089/cdd.1986.3.243. [DOI] [PubMed] [Google Scholar]
  • 31.Wahl RL, Liebert M, Biesman B, Roberts J, Jackson G, Kronberg S, Laino L. Production and characterization of a murine monoclonal antibody reactive with ovarian and other epithelial carcinomas. Proc Am Assoc Cancer Res. 1986;27:355. [Google Scholar]
  • 32.Wahl RL, Barrett J, Geatti O, Liebert M, Wilson BS, Fisher S, Wagner JG. The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage. Cancer Immunol Immunother. 1988;26:187–201. doi: 10.1007/BF00199929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Wahl RL, Wissing J, del Rosario R, Zasadny KR. Inhibition of autoradiolysis of radiolabeled monoclonal antibodies by cryopreservation. J Nucl Med. 1990;31:84–89. [PubMed] [Google Scholar]
  • 34.Yang F, Brown RS, Koral KF, Jackson G, Clavo A, Wahl RL. Quantitative autoradiographic evaluation of the influence of antibody protein dose on antibody distribution in human tumor xenografts. J Nucl Med. 1989;30:759. doi: 10.1007/BF01789014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Yonekura Y, Brill AB, Som P, Bennett GW, Fand I. Quantitative autoradiography with radiopharmaceuticals, part I: digital filmanalysis system by videodensitometry: concise communication. J Nucl Med. 1983;23:231–237. [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES